- Filed
- Oct 21, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Oct 18, 2024 | 551.5K sh |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $4.27M |
| Current Liabilities | Q2 2024 · Sep 30, 2023 | $3.43M |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $4.59M |
| Total Liabilities | Q2 2024 · Sep 30, 2023 | $3.77M |
| Current Assets | Q2 2024 · Mar 31, 2024 | $86.46K |
| Current Assets | Q2 2024 · Sep 30, 2023 | $288.42K |
| Total Assets | Q2 2024 · Mar 31, 2024 | $10.6M |
| Total Assets | Q2 2024 · Sep 30, 2023 | $10.94M |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 483.15K sh |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 483.15K sh |
| Capex | Q2 2024 · Mar 31, 2023 | $1.17M |
| Operating Cash Flow | Q2 2024 · Mar 31, 2023 | −$1.92M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $8.04M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $9.15M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $10.46M |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | −$2.30 |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | −$5.01 |
| Eps Basic restated | Q2 2024 · Mar 31, 2023 | −$2.30 |
| Eps Basic restated | Q2 2024 · Mar 31, 2023 | −$5.01 |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $1.01M |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $2.23M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$1.11M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$2.42M |
| Operating Income restated | Q2 2024 · Mar 31, 2023 | −$1.12M |
| Operating Income restated | Q2 2024 · Mar 31, 2023 | −$2.45M |
| Revenue | Q2 2024 · Mar 31, 2023 | $170.99K |
| Revenue | Q2 2024 · Mar 31, 2023 | $384.74K |